Raffaele Ornello Selected Research

Therapeutics

1/2024	Headache research in 2023: advancing therapy and technology.
1/2024	Point-Of-Care low-field MRI in acute Stroke (POCS): protocol for a multicentric prospective open-label study evaluating diagnostic accuracy.
12/2023	Health equity, care access and quality in headache - part 2.
12/2023	Anticoagulation in acute ischemic stroke patients with mechanical heart valves: To bridge or not with heparin. The ESTREM study.
10/2023	OnabotulinumtoxinA: Still the Present for Chronic Migraine.
1/2023	Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke.
1/2022	Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study.
1/2021	Multi-Center Randomized Phase II Clinical Trial on Remote Ischemic Conditioning in Acute Ischemic Stroke Within 9 Hours of Onset in Patients Ineligible to Recanalization Therapies (TRICS-9): Study Design and Protocol.
1/2020	Targeting CGRP for migraine treatment: mechanisms, antibodies, small molecules, perspectives.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raffaele Ornello Research Topics

Disease

45	Migraine Disorders (Migraine) 05/2024 - 10/2013
18	Headache (Headaches) 01/2024 - 12/2015
12	Stroke (Strokes) 04/2024 - 01/2016
8	Ischemic Stroke 04/2024 - 01/2020
4	Atrial Fibrillation 12/2023 - 01/2021
3	Cognitive Dysfunction 02/2024 - 06/2021
3	Mood Disorders (Mood Disorder) 02/2024 - 06/2021
3	Prescription Drug Overuse 01/2022 - 10/2019
2	COVID-19 07/2023 - 01/2023
2	Secondary Headache Disorders 01/2022 - 01/2021
2	Pain (Aches) 08/2021 - 01/2021
2	Dementia (Dementias) 06/2021 - 06/2021
2	Alzheimer Disease (Alzheimer's Disease) 06/2021 - 06/2021
2	Cluster Headache (Cluster Headaches) 11/2020 - 11/2018
1	Hyperglycemia 04/2024
1	Diabetes Mellitus 04/2024
1	Chronic Renal Insufficiency 04/2024
1	Heart Failure 04/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2024
1	Lacunar Stroke 02/2024
1	Dysmenorrhea (Menstrual Pain) 01/2024
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2023
1	Transient Ischemic Attack 01/2023
1	Headache Disorders (Headache Syndromes) 01/2023
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Hemorrhage 01/2022
1	Migraine without Aura (Common Migraine) 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 04/2021
1	Substance-Related Disorders (Drug Abuse) 04/2021
1	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 01/2021
1	Cerebral Hemorrhage 01/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	Post-Traumatic Headache 01/2021
1	Myasthenia Gravis 01/2020
1	Seizures (Absence Seizure) 01/2019
1	Partial Epilepsies (Epilepsy, Partial) 01/2019
1	Epilepsy (Aura) 01/2019
1	Tension-Type Headache (Tension Headache) 11/2018
1	Brain Injuries (Brain Injury) 01/2018
1	Meningoencephalitis 01/2018

Drug/Important Bio-Agent (IBA)

16	erenumabIBA 05/2024 - 10/2019
14	Monoclonal AntibodiesIBA 05/2024 - 05/2019
12	Calcitonin Gene-Related PeptideIBA 05/2024 - 05/2019
8	Tryptamines (Triptans)IBA 03/2024 - 01/2020
8	Type A Botulinum Toxins (Botox)FDA Link 10/2023 - 04/2020
5	fremanezumabIBA 12/2023 - 01/2022
4	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 06/2021
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 02/2024 - 06/2021
4	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 11/2023 - 10/2019
4	Estrogens (Estrogen)FDA Link 05/2021 - 01/2015
3	LipidsIBA 02/2024 - 06/2021
3	Vitamin K FDA Link 12/2023 - 01/2021
3	AnticoagulantsIBA 11/2023 - 01/2021
3	galcanezumabIBA 11/2023 - 01/2022
2	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 01/2024 - 01/2020
2	preemptIBA 10/2023 - 01/2023
2	mesoglycanIBA 09/2023 - 04/2023
2	salicylhydroxamic acid (SHAM)IBA 01/2022 - 11/2021
2	Gonadal Steroid Hormones (Sex Hormones)IBA 05/2021 - 11/2018
2	Analgesics (Analgesic Drugs)IBA 05/2021 - 04/2021
2	Hormones (Hormone)IBA 01/2021 - 11/2018
1	Biomarkers (Surrogate Marker)IBA 05/2024
1	MicroRNAs (MicroRNA)IBA 05/2024
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 04/2024
1	Sodium-Glucose Transport ProteinsIBA 04/2024
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 04/2024
1	Tissue Plasminogen Activator (Alteplase)FDA Link 02/2024
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2024
1	Heparin (Liquaemin)FDA LinkGeneric 12/2023
1	FlunarizineIBA 09/2023
1	Prednisolone (Predate)FDA LinkGeneric 09/2023
1	Proteins (Proteins, Gene)FDA Link 07/2023
1	Amitriptyline (Elavil)FDA LinkGeneric 04/2023
1	A 7 (A-7)IBA 01/2023
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2023
1	eptinezumabIBA 06/2022
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2022
1	VaccinesIBA 01/2022
1	SuspensionsIBA 01/2021
1	SteroidsIBA 01/2021
1	Local AnestheticsIBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2020
1	AntibodiesIBA 01/2020
1	Contraceptive Agents (Contraceptives)IBA 01/2020
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019
1	Lacosamide FDA Link 01/2019
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2019
1	Inflammation MediatorsIBA 01/2018

Therapy/Procedure

9	Therapeutics 01/2024 - 01/2020
3	Thrombectomy 04/2024 - 01/2023
3	Secondary Prevention 02/2024 - 01/2016
3	Contraindications 12/2023 - 09/2014
2	Aftercare (After-Treatment) 05/2024 - 09/2020
2	Transcranial Direct Current Stimulation 01/2022 - 11/2021
2	Nerve Block (Nerve Blocks) 01/2021 - 11/2020
2	Estrogen Replacement Therapy 01/2021 - 01/2015
1	Artificial Respiration (Mechanical Ventilation) 07/2023
1	Duration of Therapy 01/2022
1	Microbubbles 01/2022
1	Injections 01/2021